ARCHIVES

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

This article is from The Cancer Letter archive.

Vol. 20 No. 10 | March 11, 1994

Download PDF Visit The Full Archive

Related Articles

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer

November 1, 1996

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

MRI Contract: AACI Group Still Seething

August 8, 1986

Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds

January 27, 2006